Title

• The need for new therapeutic approaches and the bioartificial endocrine pancreas  
  Jean-Pierre Hallé and Paul de Vos

    1

• Different approaches for immuno-isolation  
  Paul de Vos, Bart J de Haan and Marijke M Faas

    27

• Microencapsulation technologies for a bioartificial endocrine pancreas  
  Denis Poncelet and Susan K. Tam

    37

• Alginate structure function relationships relevant to their use for cell encapsulation  
  Ýrr A. Mørch, Berit Løkensgard Strand and Gudmund Skjåk-Bræk

    51

• Characterisation and evaluation of the properties and functions of the microcapsules  
  Robert Robitaille and Jean-Pierre Hallé

    67

• Biocompatibility issues in the application of microencapsulation  
  Paul de Vos, Bart J de Haan and Marijke M Faas

    87

• Physical and chemical analysis of the microcapsule surface  
  Susan K. Tam, Jean-Pierre Hallé and L’Hocine Yahia

    97

• Visualisation techniques in the characterization of polymer microcapsules: Confocal laser scanning microscopy and atomic force microscopy  
  Igor Lacík and Dušan Chorvát Jr

    137

• Islet cell survival during isolation, microencapsulation and after transplantation  
  Julie Dusseault, Geneviève Langlois and Jean-Pierre Hallé

    177

• Improving oxygen supply to encapsulated cells and islets  
  Amy S. Lewis, Robert J. Fisher, Gordon C. Weir and Clark K. Colton

    205

• Protection of the host from the risk associated with the transplant: New role for novel microcapsules  
  Julie Dusseault and Jean-Pierre Hallé

    243

• Protection by microencapsulation from antigen recognition, immune cells, antibodies, and complement components  
  Véronique Dugas, Claudine Beauchamp, Jean-Pierre Hallé and Sylvie Lesage

    261

• Mechanisms of the host immune response to alginate microcapsules  
  Terje Espevik, Anne Mari Rokstad, Bård Kulseng, Berit Strand and Gudmund Skjåk-Bræk

    279

• Protection from cytokines by microencapsulation  
  Paul de Vos, Bart J de Haan and Marijke M Faas

    291

• Protection from free radicals by microencapsulation  
  Mahendra Kavdia

    299

• Biohybrid devices and local immunomodulation as opposed to systemic immunosuppression  
  Nicola Bocca, Peter Buchwald, R. Damaris Molano, Simona Marzorati, Cherie Stabler, Antonello Pileggi and Camillo Ricordi

    309

• Altering the islet surface: Nanoscale coatings and surface functionalization  
  Cherie L. Stabler, Kristina Finn, Kerim Gattas-Asfura and Camillo Ricordi

    329

• Implantation sites for microencapsulated islets: Rationale and lessons from experiments using different approaches  
  Francois A. Leblond and Jean-Pierre Hallé

    349

• The omental pouch as an alternative implantation site for islet transplant  
  Ziliang Ao, Peter Ao and Garth Warnock

    365

• Development of a bioartificial hypervascularized removable implantation site for encapsulated islets  
  Paul de Vos, Bart J de Haan and Marijke M Faas

    373

• Islet cell products: Processing, quality controls and implications for bioartificial applications  
  Aisha Khan, Antonello Pileggi and Camillo Ricordi

    383

• Clinical trials of islet transplantation – Experience of the Edmonton group and the international multicenter trial  
  Angela Koh, Peter Senior and A M James Shapiro

    403

• Networking applied to clinical islet transplantation: Rationale and experience from the GRAGIL network  
  Anne Wojtusciszyn, Lionel Badet, Thierry Berney, Laure Milliat-Guittard, and Pierre Y. Benhamou

    425

• Neonatal pig islet transplantation  
  George Harb, Brad Hacquoil and Gregory S. Korbutt

    439

• Microencapsulated islet xenotransplantation in the pig to primate model  
  Denis Dufrane and Pierre Gianello

    451

• Bioengineering of cells to produce insulin for the treatment of diabetes mellitus  
  Li Ren and Norman C.W. Wong

    471

• Pancreatic beta-cell mass: Exocrine pancreas- The missing link?  
  Lawrence Rosenberg, Beatrice Assouline-Thomas and Stephen Hanley

    489

• The role of integrins and extracellular matrix proteins in islet cell development and survival  
  Rennian Wang

    511

• Large-scale production of functional beta cells from stem/progenitor cells in suspension bioreactors  
  Sunghoon Jung, Arindom Sen, Michael S. Kallos, Lawrence Rosenberg, Burak Kutlu, Nathan Goodman and Leo A. Behie

    529

• Design innovation for insulin delivery systems  
  Catarina Pinto Reis, Francisco Veiga, António Ribeiro and Ronald J. Neufeld

    557

• Treatment of brain tumours with microencapsulated cell therapy  
  Simone P. Niclou and Rolf Bjerkvig

    587

• Cell microencapsulation in cancer therapy  
  Brian Salmons, Oliver Hauser, Walter Tabotta and Walter H. Gunzburg

    595

• Treatment of neurodegenerative diseases (Parkinson's, Huntington's and Alzheimer's diseases) with cell encapsulation technology  
  Jo K. Utvik and Simone P. Niclou

    607

• Application of cell micro-encapsulation for the treatment of heart diseases  
  Hao Zhang, Sheng-jun Zhu and Sheng-shou Hu

    615

• Microencapsulation for the treatment of lysosomal storage diseases  
  Murray A. Potter and Anna A. Li

    623

• Microencapsulated cell therapy of spinal cord injury, multiple sclerosis, amyotrophic lateral sclerosis and chronic pain  
  Margaret Wheatley

    649